Cushman & Wakefield brokers 53,343 s/f lease to uniQure

Cushman & Wakefield completed a 53,343 s/f office, laboratory and GMP manufacturing lease at 113 Hartwell Ave. Cushman & Wakefield executive directors Mark Winters and Richard Ruggiero represented the tenant, uniQure. The landlord is King Street Properties LLC. "We are delighted to further expand uniQure's operations with the opening of a world-class facility in the Boston area, which is one of the world's leading destinations for life science entities", said Jörn Aldag, CEO of uniQure. "The construction of this facility represents our commitment to establishing a global, fully integrated gene therapy company as we continue to build on our leadership position in the field of AAV-based gene therapy products." Stephen Lynch, principal of King Street Properties said, "The announcement that uniQure, a world leader in the life science industry, has selected Lexington for its regional base of operations speaks volumes about the quality and location of our facility. We look forward to supporting uniQure's presence in this market." uniQure's 10-year lease at 113 Hartwell Ave. will enable the firm to establish a state of the art production facility in the US which may eventually employ over 50 professionals. The building is currently undergoing extensive base building and architectural improvements designed to transform the existing 103,000 s/f building into a life science facility.